Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #192965 on NorthWest Biotherapeutics Inc (NWBO)
TiltMyBrain
10/11/18 11:53 AM
#192970 RE: Etienne1 #192965
longfellow95
10/11/18 6:43 PM
#193016 RE: Etienne1 #192965
Indeed, the unblinded data from the trial strongly supports this as was discussed at ASCO this year.
What key opinion leaders have seen from observing the unblinded data is that DCVax-L seems to have a clinically meaningful survival tail.
New data on the phase 3 trial will likely come in the form of another look at the unblinded data as was done before
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads